Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens
暂无分享,去创建一个
Yoshiyuki Suzuki | M. Kobayashi | K. Ikeda | H. Kumada | Y. Arase | T. Hosaka | F. Suzuki | Y. Kawamura | H. Sezaki | N. Akuta | S. Saitoh | Mariko Kobayashi | Shunichiro Fujiyama | M. Kobayashi